October 13, 2008 – GE Healthcare is featuring real-time imaging solutions made possible, in part, by new collaborative partnerships, at TCT 2008
The GE Innova cardiovascular X-ray system will soon be aided by the new Innova Dose, Innova 3D and Innova with Stent Technologies features. GE’s Innova Dose package aims to deliver superb image quality and custom dose management.
Intended to enhance, but not replace, 2D fluoroscopic imaging, Innova 3D imaging technique lets clinicians rapidly acquire and reconstruct 3D cardiac anatomy images right in the cath lab. Innova with Stent Technologies simplifies lesion assessment and provides exceptional stent visualization, with easy, one-button activation and can be fully integrated with Innova IVUS systems.
StentViz, a component of Innova with Stent Technologies, is currently being reviewed by the FDA and is not available for sale.
The Vivid i added 2D Intracardiac Echo (ICE) to its repertoire, introducing high performance ultrasound imagine in a space saving design. Through an expanded partnership with Biosense Webster Inc., GE adds the AcuNav 2D ICE catheter to Vivid i for invasive echocardiography procedures. This catheter enables the user to evaluate cardiac anatomy structures, guide ablation procedures and reduce the likelihood of complications during interventional procedures. The new product will be aimed at both the structural heart and electrophysiology markets.
Customers can now benefit from improved workflow in the EP and cath labs due to cooperation and compatibility between GE’s Innova cardiovascular imaging systems and Hansen Medical Systems’ robotic navigation technology. Hansen’s Sensei Robotic catheter system is a robotic navigation system that enables clinicians to place mapping catheters in hard-to-reach anatomical locations within the heart easily, accurately and with stability, even during complex cardiac arrhythmia procedures, according to GE. The Innova and Sensei systems work in conjunction at Boston’s Brigham and Women’s Hospital.
To expand its compatibility with the industry leaders in FFR technology, GE formed a collaboration with Radi Medical Systems. “Combining the strength of GE’s Mac-Lab IT hemodynamic recording cardiovascular platform and the performance of Radi's Pressurewire Aeris in the assessment of FFR has great clinical potential,” said Pascale Witz, vice president of GE Healthcare’s interventional cardiology business.
For more information: www.gehealthcare.com